BILLERICA, Mass.--(BUSINESS WIRE)--Millipore Corporation (NYSE:MIL), a leading provider of technologies, tools and services for the global life science industry, today announced it would support President-elect Barack Obama’s plans to review and possibly reverse an executive order that currently restricts federal funding for embryonic stem cell research. The comments were made by Millipore Chairman, President and CEO Martin Madaus at the JP Morgan Healthcare Conference being held this week in San Francisco, California.
